Biomarker Predicts Treatment Efficacy in Triple-Negative Breast Cancer
In this 2020 paper, researchers searched for biomarkers of sacituzumab govitecan treatment efficacy in triple-negative... read more
July 27, 2021
Tagged: breast cancer
Behind the Study: ONC201, TRAIL, and Breast Cancer
Founding Oncotarget Editorial Board Member, Dr. Wafik S. El-Deiry, and recent MD/PhD graduate of... read more
July 5, 2021
Trending With Impact: ONC201 Induces Apoptosis in Breast Cancer
A novel therapeutic combination converts anti-proliferative effects in breast cancer cells to pro-apoptotic.The Trending... read more
July 1, 2021
Trending With Impact: Low-Dose Chemo Inhibits Resistant Breast Cancer
In this trending in vitro study, researchers assessed the efficacy of low-dose 6-mercaptopurine and 5-azacitidine... read more
June 17, 2021
CRISPR Clones Shed New Light on Triple-Negative Breast Cancer
Researchers used the CRISPR-Cas9 tool to analyze a p53 mutation in triple-negative breast cancer.Research... read more
June 9, 2021
Behind the Study: Potential Therapeutic Target in Breast Cancer Cells
Dr. John Hawse from the Mayo Clinic in Minnesota, U.S., discusses his 2017 study... read more
May 17, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #9
Read short summaries of the latest research published by Oncotarget.Origin: Connecticut, ... read more
April 27, 2021
Behind the Study: Prognostic Role of mir-24-3p in Breast Cancer
Researchers from NYU discuss their 2018 study published in Oncotarget, entitled, "Prognostic role of elevated... read more
April 26, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #7
Read short summaries of the latest research literature published by Oncotarget.Origin: Quebec, CanadaInstitutions:&... read more
March 30, 2021
Behind the Study: Predictive miRNA Signature and Breast Cancer
Researchers from the University of Vermont discuss their study, published by Oncotarget in 2017, titled, "... read more
March 29, 2021